<img src="https://ml.globenewswire.com/Resource/Download/908fb457-7f8e-4a08-9081-5565e3dfb3d7?size=2" nborder="0" align="left" hspace="5" vspace="5" title="22157.jpg" alt="Company Logo"/>The India cell-based assay market is poised for growth due to increased drug discovery activities, automation in high-throughput screening, and outsourcing to CROs. Opportunities exist in 3D cell culture models, AI integration, stem cell research, oncology, and regenerative medicine, leveraging India's cost advantages.Dublin, May 13, 2026 (GLOBE NEWSWIRE) -- The <a href="https://www.researchandmarkets.com/report/india-cell-based-assay-market?utm_source=GNE&amp;utm_medium=PressRelease&amp;utm_code=zg7ttr&amp;utm_campaign=2250930+-+India+Cell+Based+Assay+Market+Forecasts+2026-2035%3a+Strategic+Government+Initiatives+Bolster+India%27s+Biopharma+Innovation&amp;utm_exec=chdomsai" rel="nofollow" target="_blank" title="India Cell Based Assay Market - Distribution by Products, Type of Assay, Technology, Application and End-user: Industry Trends and Global Forecasts, till 2035">"India Cell Based Assay Market - Distribution by Products, Type of Assay, Technology, Application and End-user: Industry Trends and Global Forecasts, till 2035"</a> has been added to ResearchAndMarkets.com's offering. The India cell-based assay market is projected to expand from USD 540 million in the current year to USD 1.17 billion by 2035, growing at a CAGR of 9.0% during the forecast period. This rapid growth is primarily fueled by increased drug discovery activities, automation in high-throughput screening, and the outsourcing of operations to Contract Research Organizations (CROs). Government and private sector investments in life sciences infrastructure are also propelling this growth, enhancing adoption across academic and commercial sectors. Emerging trends shaping this market include the adoption of 3D cell culture models, organoids, high-content imaging, and label-free technologies, integrated with AI and machine learning for data analysis. Opportunities persist in areas like stem cell research, oncology screening, regenerative medicine, and expanding biosimilar development. India's large patient population and cost advantages make it an attractive destination for global clinical and preclinical outsourcing initiatives. Growth Drivers: Strategic Enablers of Market Expansion The India cell-based assay market benefits significantly from robust government initiatives and investments in research and development spearheaded by entities such as the Department of Biotechnology (DBT) and the Biotechnology Industry Research Assistance Council (BIRAC). Through targeted subsidies, grants, and the establishment of biotech parks, these organizations facilitate seamless funding processes and endorse alternatives to animal testing. These efforts foster an innovative ecosystem, encouraging public-private partnerships and accelerating the integration of cell-based assays in drug discovery and personalized medicine applications. Market Challenges: Barriers to Overcome Despite promising growth potential, the market faces challenges such as high costs associated with advanced instruments and reagents, which can deter smaller academic labs from adopting high-throughput screening technologies. Technical complexities, variability in outcomes, and a shortage of skilled professionals further pose significant hurdles to broader adoption and scalability. Leading Market Segments The consumables segment currently dominates the market due to the continuous demand for reagents, assay kits, and other materials required for each experiment. The cell viability assay segment also holds a large market share, driven by its widespread use in drug discovery and toxicity testing. India Cell-based Assay Market: Key Segments <ul><li>Type of Product: Consumables, Instruments, Software</li><li>Type of Assay: Cell Viability, Cell Proliferation, Cytotoxicity, Cell Death, Others</li><li>By Technology: High-Throughput Screening, High-Content Screening, Flow Cytometry, Label-Free Detection</li><li>Application: Drug Discovery, Research, ADME / Toxicity Studies, Others</li><li>End-User: Pharmaceutical &amp; Biotechnology Companies, CROs, Academic / Research Institutions, Government Organizations</li></ul> Key Questions Answered in this Report <ul><li>Current engagement of India cell-based assay developers in the market</li><li>Leading companies in the market</li><li>Key market trends</li><li>Factors influencing market evolution</li><li>Primary challenges for developers</li><li>Current and future market size</li><li>Market distribution across key segments</li></ul> Reasons to Buy this Report <ul><li>Comprehensive market analysis and revenue projections</li><li>Insight into key drivers, barriers, and opportunities</li><li>Identification of customer demand and new opportunities</li><li>Effective communication and strong business relations support</li></ul> Companies Featured <ul><li>Agilent Technologies</li><li>Becton, Dickinson and Company (BD)</li><li>Bio-Rad Laboratories</li><li>Charles River Laboratories International</li><li>Corning</li><li>Danaher Corporation (including subsidiaries like Beckman Coulter)</li><li>Lonza</li><li>Merck</li><li>PerkinElmer</li><li>Promega</li><li>Revvity</li><li>Roche</li><li>Thermo Fisher Scientific</li></ul> Complementary Benefits <ul><li>Complimentary PPT Insights Packs</li><li>Excel Data Packs covering all analytical modules</li><li>Up to 15% content customization</li><li>In-depth report walkthrough with the research team</li><li>Complimentary report update if older than six months</li></ul> For more information about this report visit <a href="https://www.researchandmarkets.com/report/india-cell-based-assay-market?utm_source=GNE&amp;utm_medium=PressRelease&amp;utm_code=zg7ttr&amp;utm_campaign=2250930+-+India+Cell+Based+Assay+Market+Forecasts+2026-2035%3a+Strategic+Government+Initiatives+Bolster+India%27s+Biopharma+Innovation&amp;utm_exec=chdomsai" rel="nofollow" target="_blank" title="">https://www.researchandmarkets.com/r/ex9bn9</a> About ResearchAndMarkets.com ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends. <pre>CONTACT: 
CONTACT: ResearchAndMarkets.com 
 Laura Wood,Senior Press Manager 
 press@researchandmarkets.com
 For E.S.T Office Hours Call 1-917-300-0470 
 For U.S./ CAN Toll Free Call 1-800-526-8630 
 For GMT Office Hours Call +353-1-416-8900 

</pre> <img alt="" src='https://ml.globenewswire.com/media/ZWFjNmIzYzktZThlNS00ZGM3LWFmNjQtYTlkMTA3YTNlNDk2LTEwMjY3MzctMjAyNi0wNS0xMy1lbg==/tiny/Research-and-Markets.png' referrerpolicy='no-referrer-when-downgrade' />

GlobeNewswire Inc.

India Cell Based Assay Market Forecasts 2026-2035: Strategic Government Initiatives Bolster India's Biopharma Innovation

Latest news from the world of business and finance – both local and global

MONEY FM 89.3 is Singapore's first and only Business and Personal Finance station, featuring local and international business and financial news.

MONEY FM 89.3

Discover newsletters from our DJs on LinkedIn